Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Stupnicki

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Therapeutische Umschau. Revue Therapeutique|January 13, 2001
[Minimal craniocerebral trauma]C Sadowski-Cron, A Stupnicki, H Zimmermann
Journal of Pediatric Hematology/Oncology|November 1, 1995
Boys but not girls with T-lineage acute lymphocytic leukemia (ALL) are different from children with B-progenitor ALL. Population-based data results of initial prognostic factors and long-term event-free survival. Swiss Pediatric Oncology GroupP Imbach, A Fuchs, W Berchtold, et al.
Medical and Pediatric Oncology|August 1, 1995
Incidence of childhood acute lymphoblastic leukemia (ALL) and population-based treatment results in Switzerland: experiences with 507 study and 149 nonstudy patientsA Stupnicki, N von der Weid, P Imbach, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Therapeutische Umschau. Revue Therapeutique|January 13, 2001
[Minimal craniocerebral trauma]C Sadowski-Cron, A Stupnicki, H Zimmermann
Journal of Pediatric Hematology/Oncology|November 1, 1995
Boys but not girls with T-lineage acute lymphocytic leukemia (ALL) are different from children with B-progenitor ALL. Population-based data results of initial prognostic factors and long-term event-free survival. Swiss Pediatric Oncology GroupP Imbach, A Fuchs, W Berchtold, et al.
Medical and Pediatric Oncology|August 1, 1995
Incidence of childhood acute lymphoblastic leukemia (ALL) and population-based treatment results in Switzerland: experiences with 507 study and 149 nonstudy patientsA Stupnicki, N von der Weid, P Imbach, et al.
Pageof 1